Centene Corporation (CNC) Director Robert K. Ditmore Sells 8,750 Shares

Centene Corporation (NYSE:CNC) Director Robert K. Ditmore sold 8,750 shares of the business’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $104.13, for a total value of $911,137.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Robert K. Ditmore also recently made the following trade(s):

  • On Monday, January 8th, Robert K. Ditmore sold 8,750 shares of Centene stock. The shares were sold at an average price of $104.30, for a total value of $912,625.00.

Shares of Centene Corporation (NYSE:CNC) traded up $1.43 during midday trading on Monday, reaching $103.09. The company’s stock had a trading volume of 1,332,043 shares, compared to its average volume of 1,380,000. The firm has a market cap of $17,790.00, a PE ratio of 21.98, a PEG ratio of 0.96 and a beta of 0.71. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.93 and a quick ratio of 0.99. Centene Corporation has a 52-week low of $65.03 and a 52-week high of $112.42.

Centene (NYSE:CNC) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Centene had a return on equity of 13.68% and a net margin of 1.71%. The company had revenue of $12.81 billion during the quarter, compared to analysts’ expectations of $12.25 billion. During the same quarter in the previous year, the firm earned $1.19 EPS. Centene’s revenue was up 7.5% on a year-over-year basis. equities research analysts expect that Centene Corporation will post 7.23 earnings per share for the current fiscal year.

CNC has been the subject of several recent research reports. Oppenheimer restated a “buy” rating and issued a $105.00 price target on shares of Centene in a research note on Tuesday, October 24th. Cantor Fitzgerald restated a “buy” rating and issued a $107.00 price target on shares of Centene in a research note on Tuesday, October 24th. Cowen restated a “buy” rating and issued a $115.00 price target on shares of Centene in a research note on Tuesday, October 24th. Jefferies Group boosted their price target on Centene from $112.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, December 18th. Finally, Piper Jaffray Companies restated a “buy” rating and issued a $134.00 price target on shares of Centene in a research note on Monday, December 18th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. Centene has an average rating of “Buy” and a consensus price target of $110.28.

Several institutional investors have recently bought and sold shares of CNC. GSA Capital Partners LLP acquired a new position in shares of Centene during the 2nd quarter worth $283,000. Janus Henderson Group PLC grew its position in Centene by 320.5% during the 2nd quarter. Janus Henderson Group PLC now owns 102,870 shares of the company’s stock worth $8,216,000 after acquiring an additional 78,409 shares during the last quarter. Gotham Asset Management LLC grew its position in Centene by 3.4% during the 2nd quarter. Gotham Asset Management LLC now owns 26,192 shares of the company’s stock worth $2,092,000 after acquiring an additional 857 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new stake in Centene during the 2nd quarter worth $455,000. Finally, Raymond James Financial Services Advisors Inc. bought a new stake in Centene during the 2nd quarter worth $337,000. 92.03% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: “Centene Corporation (CNC) Director Robert K. Ditmore Sells 8,750 Shares” was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.americanbankingnews.com/2018/02/12/centene-corporation-cnc-director-robert-k-ditmore-sells-8750-shares.html.

About Centene

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Insider Buying and Selling by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply